A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease.
Guaraldi G, Cocchi S, Motta A, Ciaffi S, Codeluppi M, Bonora S, Di Benedetto F, Masetti M, Floridia M, Baroncelli S, Pinetti D, D'Avolio A, Bertolini A, Esposito R.
Guaraldi G, et al.
J Antimicrob Chemother. 2008 Dec;62(6):1356-64. doi: 10.1093/jac/dkn383. Epub 2008 Sep 5.
J Antimicrob Chemother. 2008.
PMID: 18776190
Clinical Trial.